These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 15882358

  • 1. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME, Gouras G, Relkin NR, Szabo P.
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V, Cribbs DH.
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.
    Schenk D.
    Nat Rev Neurosci; 2002 Oct; 3(10):824-8. PubMed ID: 12360327
    [No Abstract] [Full Text] [Related]

  • 10. Current progress in beta-amyloid immunotherapy.
    Schenk D, Hagen M, Seubert P.
    Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes.
    Esposito M, Luccarini I, Cicatiello V, De Falco D, Fiorentini A, Barba P, Casamenti F, Prisco A.
    Mol Immunol; 2008 Feb; 45(4):1056-62. PubMed ID: 17850871
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B.
    Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
    [Abstract] [Full Text] [Related]

  • 17. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.
    DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM.
    Proc Natl Acad Sci U S A; 2001 Jul 17; 98(15):8850-5. PubMed ID: 11438712
    [Abstract] [Full Text] [Related]

  • 18. Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease.
    Wang CY, Finstad CL, Walfield AM, Sia C, Sokoll KK, Chang TY, Fang XD, Hung CH, Hutter-Paier B, Windisch M.
    Vaccine; 2007 Apr 20; 25(16):3041-52. PubMed ID: 17287052
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Mucosal immunotherapy for alzheimer's disease with viral vectors].
    Hara H, Inoue M, Adachi K, Yonemitsu Y, Hasegawa M, Nabeshima T, Tabira T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr 20; 27(2):53-6. PubMed ID: 17515110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.